HUE056509T2 - Vegyületek huntingtin fehérje képalkotására - Google Patents

Vegyületek huntingtin fehérje képalkotására

Info

Publication number
HUE056509T2
HUE056509T2 HUE16842715A HUE16842715A HUE056509T2 HU E056509 T2 HUE056509 T2 HU E056509T2 HU E16842715 A HUE16842715 A HU E16842715A HU E16842715 A HUE16842715 A HU E16842715A HU E056509 T2 HUE056509 T2 HU E056509T2
Authority
HU
Hungary
Prior art keywords
compounds
huntingtin protein
protein imaging
imaging
huntingtin
Prior art date
Application number
HUE16842715A
Other languages
English (en)
Hungarian (hu)
Inventor
Celia Dominguez
Original Assignee
Chdi Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chdi Foundation Inc filed Critical Chdi Foundation Inc
Publication of HUE056509T2 publication Critical patent/HUE056509T2/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/041Heterocyclic compounds
    • A61K51/044Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0455Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/041Heterocyclic compounds
    • A61K51/044Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0459Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002Heterocyclic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05Isotopically modified compounds, e.g. labelled

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nuclear Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
HUE16842715A 2015-08-28 2016-08-26 Vegyületek huntingtin fehérje képalkotására HUE056509T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562211118P 2015-08-28 2015-08-28

Publications (1)

Publication Number Publication Date
HUE056509T2 true HUE056509T2 (hu) 2022-02-28

Family

ID=58103449

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE16842715A HUE056509T2 (hu) 2015-08-28 2016-08-26 Vegyületek huntingtin fehérje képalkotására

Country Status (18)

Country Link
US (3) US10137211B2 (https=)
EP (1) EP3340796B1 (https=)
JP (1) JP6944929B2 (https=)
CN (1) CN108135172B (https=)
AU (1) AU2016315648B2 (https=)
BR (1) BR112018003331B1 (https=)
CA (1) CA2995847C (https=)
DK (1) DK3340796T3 (https=)
ES (1) ES2885053T3 (https=)
HR (1) HRP20211156T1 (https=)
HU (1) HUE056509T2 (https=)
IL (1) IL257537B (https=)
MX (1) MX382156B (https=)
PL (1) PL3340796T4 (https=)
PT (1) PT3340796T (https=)
RU (1) RU2721419C2 (https=)
SI (1) SI3340796T1 (https=)
WO (1) WO2017040336A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE056957T2 (hu) 2014-08-29 2022-04-28 Chdi Foundation Inc Próbák huntingtin fehérjét megjelenítõ képalkotásra
AU2015308709B2 (en) 2014-08-29 2020-01-02 Chdi Foundation, Inc. Probes for imaging huntingtin protein
DK3197277T3 (da) 2014-08-29 2022-01-31 Chdi Foundation Inc Prober til billeddannelse af huntingtin-protein
EP3186241B1 (en) 2014-08-29 2020-10-07 CHDI Foundation, Inc. Probes for imaging huntington protein
PT3340796T (pt) 2015-08-28 2021-07-28 Chdi Foundation Inc Sondas para imagens da proteína huntingtina
EP3749225A4 (en) * 2018-02-08 2021-11-17 Phraxis Inc. ONE-PIECE ANASTOMOTIC CONNECTOR
JP7619952B2 (ja) 2019-02-25 2025-01-22 シーエイチディーアイ ファウンデーション,インコーポレーテッド 変異型ハンチンチンタンパク質を標的とするための化合物及びその使用
WO2021252775A1 (en) * 2020-06-11 2021-12-16 Chdi Foundation, Inc. Heterocyclic compounds and imaging agents for imaging huntingtin protein
CN117412960A (zh) * 2021-04-08 2024-01-16 Chdi基金会股份有限公司 用于对亨廷顿蛋白成像的异吲哚啉酮化合物和显像剂

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2126636T3 (es) 1992-05-19 1999-04-01 Adir Derivados del bencimidazol con actividad antidiabetica y antiagregante plaquetaria.
AU2241400A (en) * 1999-04-06 2000-10-12 Yamanouchi Pharmaceutical Co., Ltd. Novel thiazolobenzoimidazole derivative
JP2000351782A (ja) * 1999-04-06 2000-12-19 Yamanouchi Pharmaceut Co Ltd メタボトロピックグルタメート受容体作用薬及び新規チアゾロベンゾイミダゾール誘導体
UY27003A1 (es) 2000-11-06 2002-07-31 Schering Ag Productos radiofarmacéuticos para el diagnóstico de la enfermedad de alzheimer
US20050192314A1 (en) * 2003-11-13 2005-09-01 Ambit Biosciences Corporation Urea derivatives as C-kit modulators
TW200736252A (en) 2006-01-27 2007-10-01 Astrazeneca Ab Novel heteroaryl substituted benzothiazoles
FR2919610B1 (fr) 2007-08-02 2009-10-16 Sanofi Aventis Sa Derives de n-heteroaryl-carboxamides tricycliques,leur preparation et leur application en therapeutique
CA2731738A1 (en) * 2008-07-24 2010-01-28 Siemens Medical Solutions Usa, Inc. Imaging agents useful for identifying ad pathology
EP2218464A1 (en) * 2009-02-11 2010-08-18 Technische Universität München Compounds for non-invasive measurement of aggregates of amyloid peptides
CN103739605B (zh) * 2009-03-23 2016-08-17 伊莱利利公司 用于检测神经障碍的显像剂
WO2014011906A2 (en) 2012-07-11 2014-01-16 Nimbus Iris, Inc. Irak inhibitors and uses thereof
US9902702B2 (en) * 2014-07-15 2018-02-27 Bristol-Myers Squibb Company Spirocycloheptanes as inhibitors of rock
HUE056957T2 (hu) 2014-08-29 2022-04-28 Chdi Foundation Inc Próbák huntingtin fehérjét megjelenítõ képalkotásra
EP3186241B1 (en) 2014-08-29 2020-10-07 CHDI Foundation, Inc. Probes for imaging huntington protein
DK3197277T3 (da) 2014-08-29 2022-01-31 Chdi Foundation Inc Prober til billeddannelse af huntingtin-protein
AU2015308709B2 (en) 2014-08-29 2020-01-02 Chdi Foundation, Inc. Probes for imaging huntingtin protein
PT3340796T (pt) 2015-08-28 2021-07-28 Chdi Foundation Inc Sondas para imagens da proteína huntingtina

Also Published As

Publication number Publication date
IL257537A (en) 2018-04-30
CA2995847C (en) 2024-05-28
MX2018002338A (es) 2018-07-06
BR112018003331A2 (pt) 2018-11-06
ES2885053T3 (es) 2021-12-13
BR112018003331B1 (pt) 2022-05-10
EP3340796A1 (en) 2018-07-04
PL3340796T3 (pl) 2022-02-21
HRP20211156T1 (hr) 2021-12-24
EP3340796A4 (en) 2019-05-15
RU2018110055A (ru) 2019-09-30
US10137211B2 (en) 2018-11-27
US20190167821A1 (en) 2019-06-06
PL3340796T4 (pl) 2022-02-21
RU2018110055A3 (https=) 2019-10-28
US10765764B2 (en) 2020-09-08
RU2721419C2 (ru) 2020-05-19
IL257537B (en) 2020-08-31
JP6944929B2 (ja) 2021-10-06
MX382156B (es) 2025-03-13
AU2016315648B2 (en) 2021-04-01
US11344637B2 (en) 2022-05-31
PT3340796T (pt) 2021-07-28
CN108135172A (zh) 2018-06-08
CA2995847A1 (en) 2017-03-09
US20210060187A1 (en) 2021-03-04
EP3340796B1 (en) 2021-04-21
AU2016315648A1 (en) 2018-03-29
DK3340796T3 (da) 2021-07-26
WO2017040336A1 (en) 2017-03-09
JP2018531897A (ja) 2018-11-01
SI3340796T1 (sl) 2022-02-28
US20170056535A1 (en) 2017-03-02
CN108135172B (zh) 2021-03-30

Similar Documents

Publication Publication Date Title
IL254516B (en) Proteins specific for cd137
DK3313876T3 (da) Multispecifikke antigenbindende proteiner
IL250803B (en) Imaging means for the huntingtin protein
EP3273840C0 (en) IMAGE ANALYSIS
DK3160994T3 (da) Multispecifikke antigenbindende proteiner
DK3197453T3 (da) Kimært protein
PT3298027T (pt) Compostos depsipéptidos antelmínticos
IL257539A (en) Biopharmaceutical compositions
HUE056509T2 (hu) Vegyületek huntingtin fehérje képalkotására
IL267530A (en) Polymorphs
DK3558961T3 (da) Polymorfer
IL250805A0 (en) Imaging means for the huntingtin protein
IL250804A0 (en) Imaging means for the huntingtin protein
IL250802B (en) Imaging means for the huntingtin protein
LT3362444T (lt) Junginiai
DK3597189T3 (da) Krystallinske forbindelser
BR112018001062A2 (pt) compostos inovadores
LT3331885T (lt) Junginiai
FI20155642A (fi) Kuvantava spektrografi